New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer, according to the Oregon State ...

Researchers may have found a way to create a nuclear waste battery that could theoretically run for decades without needing to recharge.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis ...

A post-mortem preliminary report on Lilly performed by the Connecticut Veterinary Medical Diagnostic Laboratory in Storrs and dated Sept. 8, 2023, did not reveal the cause of death, with ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...

Today’s health and medical science professionals need to be proficient in their chosen field, committed to helping others, and driven to take on the unique and ever-changing challenges facing modern ...

It is used in cobalt-chromium-platinum alloys as part of the first layer ... the metal is important in improving data storage and device longevity. In medical implants, platinum alloys are found in ...

It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals ... You can purchase logo and accolade licensing to this ...

The huband-wife team will split their time between Miami and Spain.

Effective management of UC remains challenging due to the need for sustainable remission strategies, continuity of care, and access to medical services. Intelligent diagnosis refers to the use of ...

The agency will reject all data from the Chinese service provider’s studies after Mid-Link failed to address concerns outlined in a warning letter last year, FDA officials said.